Comparison of adjuvant therapy with tamoxifen and goserelin versus CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four year results of ABCSG trial 5. - Jakesz,R.; Hausmaninger,H.; Samonigg,H. (Proc Am Soc Clin Oncol, 1999)